Skip to main content
Fig. 2 | BMC Psychiatry

Fig. 2

From: CLEAR – clozapine in early psychosis: study protocol for a multi-centre, randomised controlled trial of clozapine vs other antipsychotics for young people with treatment resistant schizophrenia in real world settings

Fig. 2

SPIRIT flow diagram: Schedule of enrolment, interventions, and assessments. RA: Research Assistant; CLZ: clozapine; PANSS: Positive and Negative Syndrome Scale; CGI-S: Clinical Global Impression – Severity; CGI-I: Clinical Global Impression – Improvement; GASS-C: Glasgow Antipsychotic Side-effects Scale for Clozapine; EQ-5D-Y: Youth version of the EQ-5D; DAI-10: Drug Attitude Inventory–10 items; ReQoL-10: Recovering Quality of Life Questionnaire; EI-AD-SUS: Early Intervention Adult Service Use Schedule; CRS: Clinician Rating Scale

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us